What is Chrysalis ABA?
Chrysalis ABA is a specialized provider of Applied Behavior Analysis (ABA) therapy, dedicated to enhancing the lives of individuals diagnosed with Autism Spectrum Disorder (ASD) and other developmental disabilities. The company distinguishes itself by offering highly personalized treatment strategies, delivered through intensive one-on-one sessions. Key service offerings encompass social skills development, comprehensive care coordination, and tailored tutoring, all designed to foster independence and improve communication. Chrysalis ABA is committed to upholding rigorous standards of care and empowering its clients through evidence-based therapeutic interventions.
How much funding has Chrysalis ABA raised?
Chrysalis ABA has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
What's next for Chrysalis ABA?
The recent major strategic investment in Chrysalis ABA signals a pivotal moment for the company, likely enabling significant scaling of its operations and expansion of its service offerings. Given the large-scale late-stage funding context, Chrysalis ABA is poised to further solidify its market leadership in ABA therapy. Future initiatives may include technological integration to enhance therapy delivery, broader geographic reach, and continued development of specialized programs to address the evolving needs of individuals with developmental disabilities and their families. This capital infusion is expected to accelerate growth and innovation within the company.
See full Chrysalis ABA company page
